Logo for PolyPid Ltd

PolyPid Investor Relations Material

Latest events

Logo for PolyPid Ltd

Q3 2024

PolyPid
Logo for PolyPid

Q3 2024

13 Nov, 2024
Logo for PolyPid

Q2 2024

14 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from PolyPid Ltd

Access all reports
PolyPid Ltd. is a late-stage biopharmaceutical company focused on enhancing surgical outcomes through innovative drug delivery systems. The company's proprietary PLEX (Polymer-Lipid Encapsulation Matrix) technology is designed to enable localized, prolonged, and controlled release of active pharmaceutical ingredients at the surgical site. This technology aims to optimize therapeutic efficacy and minimize side effects by maintaining a consistent drug presence over an extended period. The company is headquartered in Petach Tikva, Israel, and its shares are listed on the NASDAQ.